File(s) under permanent embargo
A Randomised phase II study of carboplatin and bevacizumab in recurrent glioblastoma multiforme (CABARET study).
journal contribution
posted on 2023-03-17, 05:05 authored by Ann LivingstoneA Randomised phase II study of carboplatin and bevacizumab in recurrent glioblastoma multiforme (CABARET study).